Peter Buggisch

4PUBLICATIONS
34CO-AUTHORS
Medical infection agents (incl. prions)Cross-sectional analysisToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 07, 2026
Metabolic Dysfunction-Associated Steatotic Disease and Genetic Risk in Germany-An Observational Real-World Cohort Study.

|Oct 02, 2026
Healthcare Utilization and Direct Medical Costs of Hepatocellular Carcinoma Treatment - A German Claims Data Study of 2778 Patients.

|Jun 24, 2025
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results.

Cynthia Levy, Palak J Trivedi, Kris V Kowdley

|May 10, 2021
Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study.

Peter Buggisch, Hans Heiken, Stefan Mauss

Pageof 1

Frequent Collaborators

1 joint publications

Cynthia Levy

1 joint publications

Palak J Trivedi

1 joint publications

Kris V Kowdley

1 joint publications

Christopher L Bowlus